Your browser doesn't support javascript.
loading
HSP90 as a novel therapeutic target for posterior capsule opacification.
Li, Jing; Xue, Wenxian; Wang, Xuance; Huang, Weikang; Wang, Xiang-Xiang; Li, Hui; Cui, Xiukun; Li, Mengyuan; Mu, Hongmei; Ren, Yanzhu; Zhang, Fengyan; Hu, Yanzhong.
Afiliação
  • Li J; Joint National Laboratory for Antibody Drug Engineering, Henan International Union Lab of Antibody Medicine, Department of Cell Biology and Genetics, Henan University School of Basic Medical Sciences, Kaifeng, China.
  • Xue W; Joint National Laboratory for Antibody Drug Engineering, Henan International Union Lab of Antibody Medicine, Department of Cell Biology and Genetics, Henan University School of Basic Medical Sciences, Kaifeng, China.
  • Wang X; Joint National Laboratory for Antibody Drug Engineering, Henan International Union Lab of Antibody Medicine, Department of Cell Biology and Genetics, Henan University School of Basic Medical Sciences, Kaifeng, China.
  • Huang W; Joint National Laboratory for Antibody Drug Engineering, Henan International Union Lab of Antibody Medicine, Department of Cell Biology and Genetics, Henan University School of Basic Medical Sciences, Kaifeng, China.
  • Wang XX; Joint National Laboratory for Antibody Drug Engineering, Henan International Union Lab of Antibody Medicine, Department of Cell Biology and Genetics, Henan University School of Basic Medical Sciences, Kaifeng, China.
  • Li H; Joint National Laboratory for Antibody Drug Engineering, Henan International Union Lab of Antibody Medicine, Department of Cell Biology and Genetics, Henan University School of Basic Medical Sciences, Kaifeng, China.
  • Cui X; Joint National Laboratory for Antibody Drug Engineering, Henan International Union Lab of Antibody Medicine, Department of Cell Biology and Genetics, Henan University School of Basic Medical Sciences, Kaifeng, China.
  • Li M; Joint National Laboratory for Antibody Drug Engineering, Henan International Union Lab of Antibody Medicine, Department of Cell Biology and Genetics, Henan University School of Basic Medical Sciences, Kaifeng, China.
  • Mu H; Kaifeng Key Lab for Cataract and Myopia, Institute of Eye Disease, Kaifeng Central Hospital, Kaifeng, China.
  • Ren Y; Kaifeng Key Lab for Cataract and Myopia, Institute of Eye Disease, Kaifeng Central Hospital, Kaifeng, China.
  • Zhang F; Department of Ophthalmology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Hu Y; Joint National Laboratory for Antibody Drug Engineering, Henan International Union Lab of Antibody Medicine, Department of Cell Biology and Genetics, Henan University School of Basic Medical Sciences, Kaifeng, China; Department of Ophthalmology, First Affiliated Hospital of Zhengzhou University, Zhe
Exp Eye Res ; 189: 107821, 2019 12.
Article em En | MEDLINE | ID: mdl-31589841
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article